Shots: The EU label update includes additional categorization of retinal vasculitis and/or retinal vascular occlusion, usually in the intraocular inflammation. The approval follows Novartis completion of safety review and initiation […]readmore
Tags : Label Update
Shots: The EMA’s CHMP recommends an update to the Trulicity label and indication statement to include results from REWIND CV outcome study, demonstrating 12% reduction in MACE, reflecting both glycemic […]readmore
Shots: The label update includes dosing flexibility of Cosentyx up to 300 mg based on clinical response & SC structural data of 24 wks., showing inhibition in progression of joint […]readmore